Article info

Download PDFPDF

Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection
Free
  1. Correspondence to:
    L H Calabrese
    Department of Rheumatic and Immunologic Disease, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland Ohio 44195; calabrlccf.org
View Full Text

Citation

Calabrese LH, Zein N, Vassilopoulos D
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection

Publication history

  • First published October 12, 2004.
Online issue publication 
October 12, 2004

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.